Northern Trust
AVNR

Northern Trust’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Northern Trust’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,026,900
Closed -$34.4M – 4424
2014
Q4 		$34.4M Buy
2,026,900
+78,241
+4% +$1.1M 0.01% 1119
2014
Q3 		$23.2M Sell
1,948,659
-164
-0% -$1.12K 0.01% 1383
2014
Q2 		$11M Buy
1,948,823
+16,515
+0.9% +$76.1K ﹤0.01% 1971
2014
Q1 		$7.09M Sell
1,932,308
-146,187
-7% -$557K ﹤0.01% 2338
2013
Q4 		$6.98M Buy
2,078,495
+25,297
+1% +$104K ﹤0.01% 2324
2013
Q3 		$8.69M Buy
2,053,198
+13,244
+0.6% +$62.8K ﹤0.01% 2116
2013
Q2 		$9.38M Buy
+2,039,954
New +$7.01M ﹤0.01% 1969

Northern Trust's AVNR Position: Q1 2015 in Review

Northern Trust sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 2,026,900 shares — an estimated $34.4M sold.

Northern Trust first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $34.4M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Northern Trust reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Northern Trust sold 2,026,900 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $34.4M.
  • Northern Trust first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Northern Trust's AVANIR PHARMACEUTICALS, INC CL A position peaked at $34.4M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Northern Trust's 13F filing for Q1 2015, filed 14 May 2015.